Delivery Order SPE2DB22D2006-SPE2DB24FV8RH
- Not listed
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the provision of 4564445711 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,954.22 and has an ultimate completion date of May 1, 2024. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a prescription medication. The contract has a ceiling value of $2,346.24 and is a firm fixed-price contract type. The period of performance extends through August 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp's Corporate...
- This is a $2,009.37 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4565940390 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. There is no set-aside designation for this award. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4565601954 APREPITANT 80 MG CAPSULE UD 6S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $7,133.92, and a performance period ending on August 28, 2024. This award is a delivery order and is not associated with any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,213.68, is for the supply of 4,568,175,168 units of the medication Aprepitant 40 mg capsules. The award does not have a set-aside designation, indicating open competition. The contract has a period of performance through May 8, 2025. AmerisourceBergen also holds a larger $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6PDN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.78 firm fixed-price Delivery Order is for the supply of 4564978529 APREPITANT 80 MG CAPSULE UD 6S. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,390.80 Firm Fixed Price Delivery Order is for the supply of Aprepitant 80 mg capsules, a medication used to prevent nausea and vomiting associated with chemotherapy. The contract has a period of performance through June 13, 2024 and was awarded on June 12, 2024. The place of performance is Conshohocken, PA. This award is a delivery order under...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8RHDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of APREPITANT 40 MG CAPSULE UDS, a pharmaceutical product, to support military treatment programs and facilities. The total ceiling value of the contract is $2,577.54, with a period of performance ending on March 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/8/24 |